Lung Cancer: Targets and Therapy, Volume 8, Issue (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Lung Cancer: Targets and Therapy, Volume 8, Issue (2017)

See all volumes and issues
Vol 15, 2024 Vol 14, 2023 Vol 13, 2022 Vol 12, 2021 Vol 11, 2020 Vol 10, 2019 Vol 9, 2018 Volume 8, 2017 Vol 7, 2016 Vol 6, 2015 Vol 5, 2014 Vol 4, 2013 Vol 3, 2012 Vol 2, 2011 Vol 1, 2010
Download citations Download PDFs Download issue

Review

Review Article
Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
Ashwin Somasundaram & Timothy F Burns
Pages: 1-11
Published online: 21 Dec 2022
AbstractforPembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives | Full Text | References | PDF (641.4 KB)
  • 108 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
Manish K Thakur & Antoinette J Wozniak
Pages: 13-19
Published online: 21 Dec 2022
AbstractforSpotlight on necitumumab in the treatment of non-small-cell lung carcinoma | Full Text | References | PDF (191.2 KB)
  • 128 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study
Seigo Minami, Yoshitaka Ogata, Shouichi Ihara, Suguru Yamamoto & Kiyoshi Komuta
Pages: 21-30
Published online: 22 Feb 2017
AbstractforTrajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study | Full Text | References | PDF (213.3 KB)
  • 49 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects
Inbar Nardi-Agmon & Nir Peled
Pages: 31-38
Published online: 21 Dec 2022
AbstractforExhaled breath analysis for the early detection of lung cancer: recent developments and future prospects | Full Text | References | PDF (204.6 KB)
  • 318 Views
  • 33 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
Muhammad Omer Jamil, Mary S Jerome, Deborah Miley, Katri S Selander & Francisco Robert
Pages: 39-44
Published online: 21 Dec 2022
AbstractforA pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma | Full Text | References | PDF (199.8 KB)
  • 77 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
Giulio Rossi, Genny Jocollé, Antonia Conti, Marcello Tiseo, Federica Zito Marino, Giovanni Donati, Renato Franco, Francesca Bono, Francesca Barbisan & Francesco Facchinetti
Pages: 45-55
Published online: 07 Jul 2017
AbstractforDetection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives | Full Text | References | PDF (1.4 MB)
  • 164 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
Manuel Cobo, Vanesa Gutiérrez, Rosa Villatoro, Jose Manuel Trigo, Inmaculada Ramos, Omar López, María Ruiz, Ana Godoy, Irene López & Macarena Arroyo
Pages: 57-66
Published online: 12 Jul 2017
AbstractforSpotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity | Full Text | References | PDF (165.6 KB)
  • 105 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
Nagashree Seetharamu, Isabel R Preeshagul & Kevin M Sullivan
Pages: 67-78
Published online: 13 Jul 2017
AbstractforNew PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab | Full Text | References | PDF (1.1 MB)
  • 291 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-being
Rebecca H Lehto
Pages: 79-90
Published online: 21 Dec 2022
AbstractforPsychosocial challenges for patients with advanced lung cancer: interventions to improve well-being | Full Text | References | PDF (189 KB)
  • 645 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
Maiko Niki, Takashi Yokoi, Takayasu Kurata & Shosaku Nomura
Pages: 91-99
Published online: 03 Aug 2017
AbstractforNew prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer | Full Text | References | PDF (1.1 MB)
  • 74 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
Dionisios Spyratos, Eleni Papadaki, Sofia Lampaki & Theodoros Kontakiotis
Pages: 101-107
Published online: 07 Aug 2017
AbstractforChronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges | Full Text | References | PDF (141.1 KB)
  • 111 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
Mariacarmela Santarpia, Alessia Liguori, Niki Karachaliou, Maria Gonzalez-Cao, Maria Grazia Daffinà, Alessandro D’Aveni, Grazia Marabello, Giuseppe Altavilla & Rafael Rosell
Pages: 109-125
Published online: 21 Dec 2022
AbstractforOsimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy | Full Text | References | PDF (837.3 KB)
  • 494 Views
  • 31 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical staging of malignant pleural mesothelioma: current perspectives
Maria Bonomi, Costantino De Filippis, Egesta Lopci, Letizia Gianoncelli, Giovanna Rizzardi, Eleonora Cerchiaro, Luigi Bortolotti, Alessandro Zanello & Giovanni Luca Ceresoli
Pages: 127-139
Published online: 18 Aug 2017
AbstractforClinical staging of malignant pleural mesothelioma: current perspectives | Full Text | References | PDF (2.8 MB)
  • 137 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Proton beam therapy in non-small cell lung cancer: state of the art
Hideyuki Harada & Shigeyuki Murayama
Pages: 141-145
Published online: 23 Aug 2017
AbstractforProton beam therapy in non-small cell lung cancer: state of the art | Full Text | References | PDF (871.7 KB)
  • 128 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Review Article
EGFR T790M: revealing the secrets of a gatekeeper
Brian Ko, Daniel Paucar & Balazs Halmos
Pages: 147-159
Published online: 21 Dec 2022
AbstractforEGFR T790M: revealing the secrets of a gatekeeper | Full Text | References | PDF (1 MB)
  • 129 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer – significance and development
Roberto Cascone, Annalisa Carlucci, Matteo Pierdiluca, Mario Santini & Alfonso Fiorelli
Pages: 161-167
Published online: 10 Oct 2017
AbstractforPrognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer – significance and development | Full Text | References | PDF (163.6 KB)
  • 57 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib
Rohit K Jain & Hongbin Chen
Pages: 169-177
Published online: 21 Dec 2022
AbstractforSpotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib | Full Text | References | PDF (155.6 KB)
  • 75 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting
Raja Mudad, Manish B Patel, Sandra Margunato-Debay, David Garofalo & Lincy S Lal
Pages: 179-190
Published online: 19 Oct 2017
AbstractforComparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting | Full Text | References | PDF (543.7 KB)
  • 82 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan
Hiroshi Isobe, Kiyoshi Mori, Koichi Minato, Hideki Katsura, Kazuko Taniguchi, Ashwini Arunachalam, Smita Kothari, Xiting Cao & Terufumi Kato
Pages: 191-206
Published online: 24 Oct 2017
AbstractforReal-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan | Full Text | References | PDF (577.2 KB)
  • 155 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Report

Article
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
Michael Thomas, David R Spigel, Robert M Jotte, Michael McCleod, Mark A Socinski, Ray D Page, Laurent Gressot, Jeanna Knoble, Oscar Juan, Daniel Morgensztern, Dolores Isla, Edward S Kim, Howard West, Amy Ko, Teng Jin Ong, Nataliya Trunova, Cesare Gridelli & On behalf of ABOUND.sqm investigators
Pages: 207-216
Published online: 30 Oct 2017
Abstractfornab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy | Full Text | References | PDF (1.1 MB)
  • 76 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
Wolfgang Schuette, Claus-Peter Schneider, Walburga Engel-Riedel, Christian Schumann, Martin Kohlhaeufl, Monika Heidi Ursel Serke, Gert Hoeffken, Cornelius Kortsik & Martin Reck
Pages: 217-229
Published online: 06 Nov 2017
Abstractfor65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer | Full Text | References | PDF (1 MB)
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
Ewa Wojcik & Jan Kanty Kulpa
Pages: 231-240
Published online: 21 Dec 2022
AbstractforPro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response | Full Text | References | PDF (1.4 MB)
  • 321 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Case Report

Case Report
Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature
Samuel J Klempner, Pareen Mehta, Alexa B Schrock, Siraj M Ali & Sai-Hong Ignatius Ou
Pages: 241-247
Published online: 06 Dec 2017
AbstractforCis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature | Full Text | References | PDF (2.6 MB)
  • 66 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
Seigo Minami, Yoshitaka Ogata, Shouichi Ihara, Suguru Yamamoto & Kiyoshi Komuta
Pages: 249-257
Published online: 21 Dec 2022
AbstractforPretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer | Full Text | References | PDF (424.3 KB)
  • 86 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Bevacizumab in the treatment of NSCLC: patient selection and perspectives
Alessia E Russo, Domenico Priolo, Giovanna Antonelli, Massimo Libra, James A McCubrey & Francesco Ferraù
Pages: 259-269
Published online: 14 Dec 2017
AbstractforBevacizumab in the treatment of NSCLC: patient selection and perspectives | Full Text | References | PDF (197.9 KB)
  • 185 Views
  • 20 CrossRef citations
  • 0Altmetric
Open Access

Explore articles